BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20653802)

  • 1. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis.
    Yi ZM; Liu F; Zhai SD
    Int J Clin Pract; 2010 Aug; 64(9):1310-7. PubMed ID: 20653802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment issues in poststroke depression.
    Robinson RG
    Depress Anxiety; 1998; 8 Suppl 1():85-90. PubMed ID: 9809219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of poststroke depression in older people.
    Rigler SK
    Clin Geriatr Med; 1999 Nov; 15(4):765-83. PubMed ID: 10499934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of post-stroke depression with fluoxetine. A pilot project].
    Stamenkovic M; Schindler S; Kasper S
    Nervenarzt; 1996 Jan; 67(1):62-7. PubMed ID: 8676990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore.
    Tsoi WF; Tan CT; Kok LP
    Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant prophylaxis for poststroke depression: a meta-analysis.
    Chen Y; Patel NC; Guo JJ; Zhan S
    Int Clin Psychopharmacol; 2007 May; 22(3):159-66. PubMed ID: 17414742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial.
    Ruddell M; Spencer A; Hill K; House A
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):963-5. PubMed ID: 17624914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine].
    Jarema M
    Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder.
    Luo YL; Zhang MY; Wu WY; Li CB; Lu Z; Li QW
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1522-5. PubMed ID: 19733606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine as a treatment for post-traumatic stress disorder.
    Xu JJ; Chan MJ; Yang YC
    Neurosciences (Riyadh); 2011 Jul; 16(3):257-62. PubMed ID: 21677618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
    Navari RM; Brenner MC; Wilson MN
    Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.